ANCOBON Drug Patent Profile
✉ Email this page to a colleague
When do Ancobon patents expire, and what generic alternatives are available?
Ancobon is a drug marketed by Bausch and is included in one NDA.
The generic ingredient in ANCOBON is flucytosine. There are seven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the flucytosine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ancobon
A generic version of ANCOBON was approved as flucytosine by SIGMAPHARM LABS LLC on June 28th, 2011.
Summary for ANCOBON
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 209 |
Clinical Trials: | 2 |
Patent Applications: | 3,925 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ANCOBON |
What excipients (inactive ingredients) are in ANCOBON? | ANCOBON excipients list |
DailyMed Link: | ANCOBON at DailyMed |
Recent Clinical Trials for ANCOBON
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Nairobi | Phase 2 |
Bausch Health Americas, Inc. | Phase 2 |
Yale University | Phase 2 |
Pharmacology for ANCOBON
Drug Class | Nucleoside Analog Antifungal |
Anatomical Therapeutic Chemical (ATC) Classes for ANCOBON
US Patents and Regulatory Information for ANCOBON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch | ANCOBON | flucytosine | CAPSULE;ORAL | 017001-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Bausch | ANCOBON | flucytosine | CAPSULE;ORAL | 017001-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |